High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients (Q31097302)

28 June 2017

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients (English)

1 reference

28 June 2017

0 references

0 references

1 reference

Margie Hunt

3

0 references

Michael J Zelefsky

object named as

Michael J Zelefsky

series ordinal

1

0 references

C Clifton Ling

series ordinal

6

object named as

C Clifton Ling

1 reference

28 June 2017

9

Steven A Leibel

1 reference

28 June 2017

2

Zvi Fuks

1 reference

28 June 2017

7

Howard Amols

1 reference

28 June 2017

4

Yoshiya Yamada

1 reference

28 June 2017

Christine Marion

5

1 reference

PubMed ID

12128109

28 June 2017

E S Venkatraman

series ordinal

8

1 reference

PubMed ID

12128109

28 June 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

International Journal of Radiation Oncology Biology Physics

28 June 2017

1 reference

28 June 2017

53

1 reference

28 June 2017

5

1 reference

28 June 2017

1111-1116

1 reference

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

X-ray field compensation with multileaf collimators

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

The potential and limitations of the inverse radiotherapy technique

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902857-2

7 January 2021

10.1016/S0360-3016(02)02857-2

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

12128109